Ibandronate is a bisphosphonate (bis FOS fo nayt) medicine that alters bone formation and breakdown in the body. This can slow bone loss and may help prevent bone fractures.
Bonviva is a drug made in Colombia, Cyprus, Ecuador, Georgia, Hong Kong, Lebanon, Malaysia, Myanmar, Paraguay, Peru, Philippines, Thailand. You need a doctor's prescription to buy it. But its analogues can be bought online anywhere in the world without going to a specialist.
Ibandronate is a complete analogue of Bonviva. It has the same composition, dosage and methods of use. Also Ibandronate has a lower cost compared to Bonviva.
To buy Bonviva, click on the "buy now" button and then in our online store select the medicine and the desired dosage. Follow the instructions below.
Free delivery is valid for purchases from $200. We deliver medicines around the world and provide the best prices.
You can also use a coupon giving a 5% discount.
Side effects
Get emergency medical help if you have even mild symptoms: pain or burning under the ribs or in the back; chest pain, new or worsening heartburn; new or unusual pain in your thigh or hip; jaw pain, numbness, or swelling; severe joint, bone, or muscle pain; or heartburn, stomach pain, diarrhea; headache; or pain in your arms or legs;
Warnings
It is not known whether ibandronate will harm an unborn baby. Tell your doctor if you are pregnant or plan to become pregnant.
Talk with your doctor about the risks and benefits of using this medication.
It is not known whether ibandronate passes into breast milk or if it could harm a nursing baby. Tell your doctor if you are breast-feeding a baby.
Interactions
Nonsteroidal Anti-Inflammatory Agents: May enhance the adverse/toxic effect of Bisphosphonate Derivatives. Both an increased risk of gastrointestinal ulceration and an increased risk of nephrotoxicity are of concern. Monitor therapy
Aminoglycosides: May enhance the hypocalcemic effect of Bisphosphonate Derivatives. Monitor therapy
Proton Pump Inhibitors: May diminish the therapeutic effect of Bisphosphonate Derivatives. Monitor therapy
Food interaction
Take on an empty stomach. All foods markedly reduce (up to 90%) ibandronate bioavailabilty. Take with plain water (not mineralized) at least 1 hour before any food. Bioavailability and effect on bone density are both impaired if the patient eats or drinks in less than 1 hour after taking this product. Drink a large glass of water and stay in an upright position for at least 60 minutes after taking this product.
Pregnancy
- Women who can get pregnant must take monthly pregnancy tests.
- If it is for a young person who could be pregnant.
- Treatment of intrauterine fetal death not accompanied by complete expulsion of products of conception in second and third trimesters of pregnancy.
Overview
Storage conditions
At a temperature not exceeding 30 ° C.
The prepared solution for infusion is stable for 24 hours at a temperature of 2-8 ° C.
Keep out of the reach of children.
Pharmacy Vacation Terms
On prescription.
Owner of Registration Certificate
F. Hoffmann-La Roche Ltd., Grenzacherstrasse 124, 4070 Basel, Switzerland
F. Hoffmann-La Roche Ltd., Grenzacherstrasse Bonviva, 4070 Basel, Switzerland
Manufacturer
Roche Diagnostics GmbH, Sandhofer Strasse 116, D-68305 Mannheim, Germany
Roche Diagnostics GmbH, Sandhofer Strasse 116, D-68305 Mannheim, Germany
Claims of consumers should be sent to the address of the Representative Office F. Hoffmann-La Roche Ltd.:
2, Trubnaya Ploshchad, 107031, Russia, Moscow
Bonviva is a drug from the pharmacological group of drugs, the action of which is aimed at the treatment of bone tissue.
The drug is used during the treatment of osteoporosis in patients with menopause. According to the results of clinical studies, it was found that the use of Bonviva means prevents the development of spinal fractures in women.
On this page you will find all the information about Bonviva: complete instructions for use for this drug, average prices in pharmacies, complete and incomplete analogues of the drug, as well as reviews of people who have already used Bonviva. Want this drug leave your opinion? Please write in the comments.
Bone resorption inhibitor in osteoporosis in postmenopausal women.
Dispensed by prescription.
How much does Bonviva cost? The average price in pharmacies is at 1,900 per tablet, and 5,000 rubles. per solution.
The drug Bonviva is available in dosage form coated tablets. Tablets are packaged in a blister pack of 14 pieces, a cardboard pack contains 2 blisters (28 tablets) and instructions for use of the drug.
One tablet contains the active substance ibandronic acid in an amount of 150 mg. Also contains auxiliary substances, which include:
- Stearic acid.
- Silica colloidal anhydrous.
- Tatane dioxide.
- Lactose Monohydrate.
- Microcrystalline cellulose.
Jantoven K 25. - Crospovidone.
- Hypromellose.
- Macrogol 6000.
- Talc.
Ibandronic acid is a highly active nitrogen-containing bisphosphonate, an inhibitor of bone resorption and osteoclast activity. Ibandronic acid prevents the development of bone destruction caused by blockade of the function of the gonads, retinoids, tumors and tumor extracts in vivo. Does not violate bone mineralization when Bonviva in doses up to 5000 times higher than those used for treatment of osteoporosis. Does not affect the replenishment of the pool of osteoclasts. The selective effect of ibandronic acid on bone tissue is due to its high affinity for hydroxyapatite, which makes up the bone mineral matrix.
Ibandronic acid inhibits bone resorption dose-dependently and does not directly affect this list formation. In women during menopause, it reduces the increased rate of bone tissue renewal to the level of reproductive age, which leads to a progressive increase in bone mass, a decrease in the rate of bone collagen breakdown in urine and blood serum, the frequency of fractures and an increase in bone mineral density.
Bonviva tablets and injections are indicated for use in preventing fractures in women with postmenopausal osteoporosis in order to reduce bone fragility.
For Bonviva dosage forms of Bonviva
- Hypocalcemia;
- Hypersensitivity of the patient to the components of the drug.
For solution and tablets of 2.5 mg:
Additionally for the solution:
